1. Home
  2. JAGX vs PAVM Comparison

JAGX vs PAVM Comparison

Compare JAGX & PAVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Jaguar Health Inc.

JAGX

Jaguar Health Inc.

HOLD

Current Price

$3.68

Market Cap

2.5M

Sector

Health Care

ML Signal

HOLD

Logo PAVmed Inc.

PAVM

PAVmed Inc.

N/A

Current Price

$2.22

Market Cap

41.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
JAGX
PAVM
Founded
2013
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5M
41.1M
IPO Year
2014
2015

Fundamental Metrics

Financial Performance
Metric
JAGX
PAVM
Price
$3.68
$2.22
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
★ $36.50
AVG Volume (30 Days)
★ 4.4M
18.5K
Earning Date
11-16-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 82.42
N/A
EPS
N/A
★ N/A
Revenue
★ $11,511,000.00
$3,000,000.00
Revenue This Year
$77.78
$132.39
Revenue Next Year
N/A
$263.64
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 20.00
52 Week Low
$0.20
$0.21
52 Week High
$41.53
$52.00

Technical Indicators

Market Signals
Indicator
JAGX
PAVM
Relative Strength Index (RSI) 48.05 28.01
Support Level $0.49 N/A
Resistance Level $7.63 $6.56
Average True Range (ATR) 0.92 0.28
MACD -0.43 -0.02
Stochastic Oscillator 9.70 9.73

Price Performance

Historical Comparison
JAGX
PAVM

About JAGX Jaguar Health Inc.

Jaguar Health Inc is a commercial-stage pharmaceutical company developing novel proprietary prescription medicines sustainably derived from plants from rainforest areas for gastrointestinal disease states in humans and animals. The Company focuses on conditions associated with overactive bowel, including chronic debilitating diarrhea, urgency, and bowel incontinence. It operates through two segments: animal health, which develops and commercializes products for animals, and human health, with the human health segment generating the maximum revenue and focusing on products such as Mytesi, focusing on human products, specifically Mytesi, approved for symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy.

About PAVM PAVmed Inc.

PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, EsoCheck, and the Veris Cancer Care Platform.

Share on Social Networks: